Form 8-K - Current report:
SEC Accession No. 0001437749-25-006685
Filing Date
2025-03-07
Accepted
2025-03-07 16:30:20
Documents
14
Period of Report
2025-03-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K atxi20250307_8k.htm   iXBRL 8-K 38740
  Complete submission text file 0001437749-25-006685.txt   175815

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA atxi-20250307.xsd EX-101.SCH 3408
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20250307_def.xml EX-101.DEF 11423
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20250307_lab.xml EX-101.LAB 15309
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20250307_pre.xml EX-101.PRE 11583
16 EXTRACTED XBRL INSTANCE DOCUMENT atxi20250307_8k_htm.xml XML 2847
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

EIN.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38114 | Film No.: 25720558
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)